WoundScribe AI
Share
X Facebook WhatsApp Email

Skin Substitutes and WISeR: FAQ for Wound Care Billing in 2026

compliance

Published

Direct answers to the most common questions wound care billers and clinicians are asking about skin substitutes under the WISeR prior authorization model.

Skin substitutes are the highest-dollar target under WISeR. These are the questions we hear most from billing leads and wound care clinicians preparing for January 2026.

Are skin substitutes covered the same way under WISeR?

Yes. WISeR does not change coverage rules or payment rates. It changes when the review happens — before payment instead of after. If a graft was covered in 2025, the same clinical criteria apply in 2026; you just have to prove them up front.

Do I have to submit prior authorization for every skin substitute application?

For affected HCPCS codes in the six WISeR states, yes — unless you accept pre-payment review instead. Both paths trigger the same clinical review; you're only choosing timing. Clinics with a Gold Card exemption on a specific service can skip prior auth for that service.

What documentation do reviewers want on a skin substitute request?

At minimum: wound type and location, exact measurements over time, weeks the wound has been present, documented failure of at least four weeks of standard conservative care, vascular assessment, and comorbidity management (glycemic control for DFUs, offloading, compression for VLUs). Templated language is the top reason clinically appropriate care gets non-affirmed.

How fast is a decision?

Standard reviews: three business days. Expedited: two business days when a delay could jeopardize the patient's health.

What if we get a non-affirmation?

Most non-affirmations are documentation gaps. Options: resubmit with better evidence, request a peer-to-peer, or file a standard appeal. Payment is not permanently denied — the underlying coverage rules haven't changed.

Can AI deny our claim?

No. CMS requires that every non-affirmation be issued by a licensed clinician. AI can screen and route, but a human clinician signs the decision.

How does this affect our revenue cycle?

Expect cash cycles to lengthen on affected services during the first quarter as workflows adjust. Clinics that build prior auth into scheduling — rather than treating it as a back-office task — see the smallest disruption. See Skin substitutes after the 2026 CMS rule for the payment-rate side of the picture.

Where can I read the full model details?

Start with the WISeR Model FAQ for wound care clinics and the WoundScribe WISeR Program overview.